Empresaria Group (EMR) Competitors GBX 44.20 +1.20 (+2.79%) As of 08/1/2025 11:23 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock EMR vs. GATC, RTC, HAS, PAGE, IPEL, STEM, NBB, RWA, STAF, and GORShould you be buying Empresaria Group stock or one of its competitors? The main competitors of Empresaria Group include Gattaca (GATC), RTC Group (RTC), Hays (HAS), PageGroup (PAGE), Impellam Group (IPEL), SThree (STEM), Norman Broadbent (NBB), Robert Walters (RWA), Staffline Group (STAF), and Gordon Dadds Group (GOR). These companies are all part of the "industrials" sector. Empresaria Group vs. Its Competitors Gattaca RTC Group Hays PageGroup Impellam Group SThree Norman Broadbent Robert Walters Staffline Group Gordon Dadds Group Gattaca (LON:GATC) and Empresaria Group (LON:EMR) are both small-cap industrials companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership, media sentiment and dividends. Does the media refer more to GATC or EMR? In the previous week, Gattaca had 2 more articles in the media than Empresaria Group. MarketBeat recorded 2 mentions for Gattaca and 0 mentions for Empresaria Group. Gattaca's average media sentiment score of 0.00 equaled Empresaria Group'saverage media sentiment score. Company Overall Sentiment Gattaca Neutral Empresaria Group Neutral Do insiders and institutionals believe in GATC or EMR? 11.8% of Gattaca shares are held by institutional investors. Comparatively, 27.5% of Empresaria Group shares are held by institutional investors. 63.8% of Gattaca shares are held by insiders. Comparatively, 60.0% of Empresaria Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is GATC or EMR a better dividend stock? Gattaca pays an annual dividend of GBX 3 per share and has a dividend yield of 3.3%. Empresaria Group pays an annual dividend of GBX 1 per share and has a dividend yield of 2.3%. Gattaca pays out 484.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Empresaria Group pays out -7.9% of its earnings in the form of a dividend. Which has better valuation and earnings, GATC or EMR? Gattaca has higher revenue and earnings than Empresaria Group. Empresaria Group is trading at a lower price-to-earnings ratio than Gattaca, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGattaca£370.86M0.07£177.08K£0.62146.95Empresaria Group£235.95M0.09-£5.75M-£12.58-3.51 Which has more risk and volatility, GATC or EMR? Gattaca has a beta of 2.14, indicating that its share price is 114% more volatile than the S&P 500. Comparatively, Empresaria Group has a beta of 0.7, indicating that its share price is 30% less volatile than the S&P 500. Is GATC or EMR more profitable? Gattaca has a net margin of 0.05% compared to Empresaria Group's net margin of -2.44%. Gattaca's return on equity of 0.65% beat Empresaria Group's return on equity.Company Net Margins Return on Equity Return on Assets Gattaca0.05% 0.65% 1.44% Empresaria Group -2.44%-17.70%2.08% SummaryGattaca beats Empresaria Group on 10 of the 14 factors compared between the two stocks. Get Empresaria Group News Delivered to You Automatically Sign up to receive the latest news and ratings for EMR and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EMR vs. The Competition Export to ExcelMetricEmpresaria GroupStaffing & Employment Services IndustryIndustrials SectorLON ExchangeMarket Cap£20.78M£504.88M£7.60B£3.03BDividend Yield3.83%5.93%4.56%5.02%P/E Ratio-3.5142.7625.25176.75Price / Sales0.09109.6598.63264,362.45Price / Cash1.1814.6327.7627.97Price / Book0.579.324.314.53Net Income-£5.75M£10.32M£792.92M£5.90B7 Day Performance105.10%2.81%-1.95%12.58%1 Month Performance75.75%2.61%2.25%6.10%1 Year Performance14.81%130.11%29.27%71.60% Empresaria Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EMREmpresaria GroupN/AGBX 44.20+2.8%N/A+13.3%£20.78M£235.95M-3.513,150Gap DownHigh Trading VolumeGATCGattacaN/AGBX 88-2.2%N/A+0.0%£26.42M£370.86M142.11446News CoverageRTCRTC GroupN/AGBX 104.25+1.7%N/A-5.4%£13.49M£90.27M7.35361Earnings ReportHASHays3.1587 of 5 starsGBX 64.35-0.2%GBX 107.50+67.1%-33.5%£1.01B£6.91B-206.436,490Gap UpPAGEPageGroupN/AGBX 267-1.0%GBX 450+68.5%-39.2%£836.65M£1.87B16.527,859Gap DownIPELImpellam GroupN/AN/AN/AN/A£389.29M£2.04B2,500.001,783STEMSThree4.1887 of 5 starsGBX 212-3.9%GBX 350+65.1%-48.1%£276.74M£1.47B5.612,280News CoverageEarnings ReportAnalyst ForecastInsider TradeGap UpNBBNorman BroadbentN/AGBX 195flatN/A+2,551.6%£121.14M£10.98M507.2152RWARobert Walters4.055 of 5 starsGBX 159-6.5%GBX 350+120.1%-61.1%£113.45M£1.07B18.353,980News CoverageEarnings ReportAnalyst ForecastSTAFStaffline GroupN/AGBX 43.20+3.8%N/A+2.6%£56.04M£896.86M-2.972,300Earnings ReportInsider TradeGap UpGORGordon Dadds GroupN/AN/AN/AN/A£51.21M£52.58M-4.83344 Related Companies and Tools Related Companies Gattaca Competitors RTC Group Competitors Hays Competitors PageGroup Competitors Impellam Group Competitors SThree Competitors Norman Broadbent Competitors Robert Walters Competitors Staffline Group Competitors Gordon Dadds Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:EMR) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Empresaria Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Empresaria Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EMR Stock Alerts